STRATA CRITICAL MEDICAL ($SRTA) posted quarterly earnings results for Q1 2026 on Wednesday, May 6th. The company reported earnings of $0.03 per share, beating estimates of -$0.04 by $0.07. The company also reported revenue of $67,380,000, beating estimates of $64,948,500 by $2,431,500.
You can see Quiver Quantitative's $SRTA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
STRATA CRITICAL MEDICAL Insider Trading Activity
STRATA CRITICAL MEDICAL insiders have traded $SRTA stock on the open market 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SRTA stock by insiders over the last 6 months:
- REGINALD LOVE has made 0 purchases and 2 sales selling 22,000 shares for an estimated $95,504.
- WILLIAM A. HEYBURN (Co-CEO and CFO) purchased 17,000 shares for an estimated $76,044
- ANDREW LAUCK purchased 5,000 shares for an estimated $21,825
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
STRATA CRITICAL MEDICAL Hedge Fund Activity
We have seen 60 institutional investors add shares of STRATA CRITICAL MEDICAL stock to their portfolio, and 64 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTHERN RIGHT CAPITAL MANAGEMENT, L.P. added 2,869,014 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,799,957
- CANNELL CAPITAL LLC removed 1,598,489 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $7,688,732
- ARK INVESTMENT MANAGEMENT LLC added 706,075 shares (+11.0%) to their portfolio in Q4 2025, for an estimated $3,396,220
- ROYCE & ASSOCIATES LP added 703,086 shares (+67.5%) to their portfolio in Q4 2025, for an estimated $3,381,843
- DIMENSIONAL FUND ADVISORS LP removed 380,615 shares (-20.8%) from their portfolio in Q4 2025, for an estimated $1,830,758
- QUBE RESEARCH & TECHNOLOGIES LTD removed 369,573 shares (-82.2%) from their portfolio in Q4 2025, for an estimated $1,777,646
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 336,199 shares (+18.7%) to their portfolio in Q4 2025, for an estimated $1,617,117
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
STRATA CRITICAL MEDICAL Analyst Ratings
Wall Street analysts have issued reports on $SRTA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 12/02/2025
To track analyst ratings and price targets for STRATA CRITICAL MEDICAL, check out Quiver Quantitative's $SRTA forecast page.
STRATA CRITICAL MEDICAL Price Targets
Multiple analysts have issued price targets for $SRTA recently. We have seen 3 analysts offer price targets for $SRTA in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- Bill Bonello from Craig-Hallum set a target price of $8.0 on 03/25/2026
- Yuan Zhi from B. Riley Securities set a target price of $8.0 on 03/25/2026
- Benjamin Haynor from Lake Street set a target price of $8.0 on 12/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
